3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
4
Tumor-Agnostic
2
Plasma cell
1
Dermatologic
1
Conditions
Multiple Myeloma
20
Lymphoma
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Smoldering Multiple Myeloma
1
Sarcoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Disease
1
Carcinoma
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Lenalidomide
5
Dexamethasone
4
fludarabine phosphate
2
daratumumab
2
Whole-Body Irradiation
2
Cyclophosphamide
2
Calcium Dobesilate
2
talquetamab
1
selinexor
1
ixazomib
1
isatuximab
1
fludarabine
1
Transplantation, Autologous
1
Sirolimus
1
Rituximab
1
Mycophenolic Acid
1
Melphalan
1
Bortezomib
1
Blood Specimen Collection
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT02627261
2022-09-06
MMRD
Hospices Civils de Lyon
Completed
48 enrolled